Blood metabolite markers of cognitive performance and brain function in aging

Journal of Cerebral Blood Flow and Metabolism

Volumn 36, Issue 7, 2016, Pages 1212-1223

  Simpson, Brittany N ^a,b   Kim, Min ^c   Chuang, Yi Fang ^a   Beason Held, Lori ^d   Kitner Triolo, Melissa ^d   Kraut, Michael ^e   Lirette, Seth T ^f   Windham, B Gwen ^b   Griswold, Michael E ^b   Legido Quigley, Cristina ^c   Thambisetty, Madhav ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d NATIONAL INSTITUTE ON AGING   (United States)

^e DEPARTMENT OF PATHOLOGY   (United States)

^f UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease's; biomarker; phosphatidylcholine; positron emission tomography imaging; verbal memory

Indexed keywords

BIOLOGICAL MARKER; PHOSPHATIDYLCHOLINE;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; ASSESSMENT OF HUMANS; BENTON VISUAL RETENTION TEST; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN REGION; CALIFORNIA VERBAL LEARNING TEST; CARD ROTATION TEST; COGNITION; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; EXECUTIVE FUNCTION; FEMALE; FLUENCIES CATEGORY AND LETTER; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRAIL MAKING TEST; VERBAL MEMORY; BLOOD; BRAIN; BRAIN CIRCULATION; COGNITIVE DEFECT; DIAGNOSTIC IMAGING; FUNCTIONAL NEUROIMAGING; METABOLISM; PHYSIOLOGY; VASCULARIZATION;

AGED; AGING; ALZHEIMER DISEASE; BIOMARKERS; BRAIN; CEREBROVASCULAR CIRCULATION; COGNITION; COGNITION DISORDERS; FEMALE; FUNCTIONAL NEUROIMAGING; HUMANS; LONGITUDINAL STUDIES; MALE; PHOSPHATIDYLCHOLINES; POSITRON-EMISSION TOMOGRAPHY;

EID: 84976871163     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X15611678     Document Type: Article

References (48)

1. Hebert LE, Weuve J, Scherr PA, et al. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 2013; 19: 1778-1783
2. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer Dement 2011; 3: 270-279
3. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer Dement 2011; 3: 263-269
4. Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer Dement 2011; 3: 280-292
5. O'Bryant SE, Xiao G, Barber R, et al. A blood-based screening tool for Alzheimer's disease that spans serum, and plasma: findings from TARC, and ADNI. PLoS One 2011; 12: e28092
6. Thambisetty M, and Lovestone S. Blood-based biomarkers of Alzheimer's disease: challenging but feasible. Biomark Med 2010; 1: 65-79
7. Mishur RJ, and Rea SL. Applications of mass spectrometry to metabolomics, and metabonomics: detection of biomarkers of aging, and of age-related diseases. Mass Spectrom Rev 2012; 1: 70-95
8. Trushina E, and Mielke MM. Recent advances in the application of metabolomics to Alzheimer's disease. Biochim Biophys Acta 2014; 8: 1232-1239
9. Xu XH, Huang Y, Wang G, et al. Metabolomics: a novel approach to identify potential diagnostic biomarkers, and pathogenesis in Alzheimer's disease. Neurosci Bull 2012; 5: 641-648
10. Lewis GD, and Gerszten RE. Toward metabolomic signatures of cardiovascular disease. Circ Cardiovasc Genet 2010; 2: 119-121
11. Whiley L, Sen A, Heaton J, et al. Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease. Neurobiol Aging 2014; 2: 271-278
12. Mapstone M, Cheema AK, Fiandaca MS, et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med 2014; 20: 415-418
13. Ferrucci L. The Baltimore Longitudinal Study of Aging (BLSA): a 50-year-long journey, and plans for the future. J Gerontol A Biol Sci Med Sci 2008; 12: 1416-1419
14. Shock NW, Greulich RC, Costa PT, et al. Normal human aging: the Baltimore longitudinal study of aging. Washington, DC: U.S. Department of Health, and Human Services, Public Health Service, National Institutes of Health, National Institute on Aging, Gerontology Research Center, Baltimore City Hospitals, 1984
15. Resnick SM, Goldszal AF, Davatzikos C, et al. One-year age changes in MRI brain volumes in older adults. Cereb Cortex 2000; 5: 464-472
16. Williams JBW. American Psychiatric Association. Diagnostic criteria from DSM-III-R. Washington, DC: American Psychiatric Association, 1987
17. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health, and Human Services Task Force on Alzheimer's disease. Neurology 1984; 7: 939-944
18. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 3: 183-194
19. Johnson WE, Li C, and Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007; 1: 118-127
20. Delis DC, Freeland J, Kramer JH, et al. Integrating clinical assessment with cognitive neuroscience: construct validation of the California Verbal Learning Test. J Consult Clin Psychol 1988; 1: 123
21. Reitan RM. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 1958; 3: 271-276
22. Folstein MF, Folstein SE, and McHugh PR. 'Minimental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 3: 189-198
23. Benton A. The revised visual retention test. New York, NY: Psychological Corporation, 1974
24. Ekstrom RB, French JW, Harman HH, et al. Manual for kit of factor referenced cognitive tests. Princeton, NJ: Educational Testing Service, 1976
25. Newcombe F. Missile wounds of the brain. London, UK: Oxford University Press, 1969
26. Benton AL. Differential behavioral effects in frontal lobe disease. Neuropsychologia 1968; 1: 53-60
27. Hadi AS. Identifying multiple outliers in multivariate data. J R Stat Soc Series B Stat Methodol 1992; 54: 761-771
28. Terracciano A, Balaci L, Thayer J, et al. Variants of the serotonin transporter gene, and NEO-PI-R neuroticism: no association in the BLSA, and SardiNIA samples. Am J Med Genet B Neuropsychiatr Genet 2009; 8: 1070-1077
29. Beason-Held LL, Goh JO, An Y, et al. Changes in brain function occur years before the onset of cognitive impairment. J Neurosci 2013; 33: 18008-18014
30. Thambisetty M, Beason-Held LL, An Y, et al. Alzheimer risk variant clusterin (CLU), and brain function in aging. Biol Psychiatry 2013; 73: 399-405
31. Thambisetty M, Beason-Held LL, An Y, et al. Impaired glucose tolerance in midlife, and longitudinal changes in brain function during aging. Neurobiol Aging 2013; 34: 2271-2276
32. Jueptner M, and Weiller C. Review: does measurement of regional cerebral blood flow reflect synaptic activity?. Implications for PET, and fMRI. Neuroimage 1995; 2: 148-156
33. Klingberg T, Kawashima R, and Roland PE. Activation of multi-modal cortical areas underlies short-Term memory. Eur J Neurosci 1996; 9: 1965-1971
34. Klingberg T. Concurrent performance of two working memory tasks: potential mechanisms of interference. Cereb Cortex 1998; 7: 593-601
35. Salo E, Rinne T, Salonen O, et al. Brain activity during auditory, and visual phonological, spatial, and simple discrimination tasks. Brain Res 2013; 1496: 55-69
36. Huijbers W, Pennartz CM, Rubin DC, et al. Imagery, and retrieval of auditory, and visual information: neural correlates of successful, and unsuccessful performance. Neuropsychologia 2011; 7: 1730-1740
37. Brassen S, Weber-Fahr W, Sommer T, et al. Hippocampal-prefrontal encoding activation predicts whether words can be successfully recalled or only recognized. Behav Brain Res 2006; 2: 271-278
38. Johnson SC, Saykin AJ, Flashman LA, et al. Brain activation on fMRI, and verbal memory ability: functional neuroanatomic correlates of CVLT performance. J Int Neuropsychol Soc 2001; 1: 55-62
39. Rosazza C, Minati L, Ghielmetti F, et al. Engagement of the medial temporal lobe in verbal, and nonverbal memory: assessment with functional MR imaging in healthy subjects. AJNR Am J Neuroradiol 2009; 6: 1134-1141
40. Mielke MM, Bandaru VVR, Haughey NJ, et al. Serum sphingomyelins, and ceramides are early predictors of memory impairment. Neurobiol Aging 2010; 1: 17-24
41. Oresic M, Hyotylainen T, Herukka SK, et al. Metabolome in progression to Alzheimer's disease. Transl Psychiatry 2011; 12: e57
42. Trushina E, Dutta T, Persson X-MT, et al. Identification of altered metabolic pathways in plasma, and CSF in mild cognitive impairment, and Alzheimer's disease using metabolomics. PloS One 2013; 5: e63644
43. Cramer PE, Cirrito JR, Wesson DW, et al. ApoE-directed therapeutics rapidly clear beta-Amyloid, and reverse deficits in AD mouse models. Science 2012; 6075: 1503-1506
44. Sanchez-Mejia RO, and Mucke L. Phospholipase A2, and arachidonic acid in Alzheimer's disease. Biochim Biophys Acta 2010; 8: 784-790
45. Gaudin M, Panchal M, Auzeil N, et al. Choline-containing phospholipids in microdissected human Alzheimer's disease brain senile plaque versus neuropil. Bioanalysis 2012; 17: 2153-2159
46. Browning LM, Walker CG, Mander AP, et al. Incorporation of eicosapentaenoic, and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish. Am J Clin Nutr 2012; 96: 748-758
47. Luchtman DW, and Song C. Cognitive enhancement by omega-3 fatty acids from child-hood to old age: findings from animal, and clinical studies. Neuropharmacology 2013; 64: 550-565
48. Cunnane SC, Chouinard-Watkins R, Castellano CA, et al. Docosahexaenoic acid homeostasis, brain aging, and Alzheimer's disease: can we reconcile the evidence?. Prostaglandins Leukot Essent Fatty Acids 2013; 88: 61-70